Guiding blood transfusions during procedures for cirrhosis
Part of Blood & lymphatic, Digestive system clinical trials.
This study compares a special blood test (thrombelastometry) to standard tests to decide when to give blood products before invasive procedures in people with advanced liver cirrhosis. The goal is to see which method leads to better use of blood products and fewer complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced liver cirrhosis (decompensated).
- You are scheduled for a procedure that has a high risk of bleeding.
- Your standard blood tests show you have a clotting problem, and your doctor is thinking about giving you blood products beforehand.
- You are able and willing to give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies bleeding problems in people with advanced liver cirrhosis or liver cancer. It aims to improve understanding of when blood transfusions or treatments are needed.
This trial tests whether using a slightly different target on a blood-clotting test (ROTEM) can reduce the need for blood transfusions in people with liver disease who need a procedure. If you have cirrhosis or ACLF with severe clotting problems, this study may help your doctors decide how much blood product to give you before the procedure.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
This trial is testing if a special blood test called ROTEM can help doctors predict the risk of bleeding after high-risk procedures in people with cirrhosis. It aims to improve safety and guide treatment decisions.
This study tests ways to reduce the need for blood transfusions during major liver surgery. Researchers will track patients undergoing large liver resections to see if new blood-management techniques can help you need fewer transfusions while staying safe.
This study looks at microRNA (tiny molecules in blood) to better understand what’s happening during sudden worsening of cirrhosis. It may help doctors recognize and monitor decompensated cirrhosis more accurately.
Hear when a new Liver Cirrhosis With Acute Decompensation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.